Directory
>
Murali Mallem
Murali Mallem
Vice President | Head of CMC | Entrada Therapeutics
Boston, Massachusetts, United States
Murali Mallem
Summary
Murali Mallem is an accomplished Vice President and Head of CMC at Entrada Therapeutics, specializing in the biopharmaceutical industry. With extensive experience in assay development, biochemistry, and biopharmaceuticals, he has held significant roles in leading teams and projects at top companies like Bristol Myers Squibb and Merck. His educational background includes advanced degrees in Chemical Engineering and Management, which complement his technical expertise. Murali's career spans over 18 years, showcasing a commitment to innovation in drug discovery and development processes. He has a proven track record in managing complex projects and driving technology transfer initiatives. His leadership style emphasizes collaboration and strategic thinking, making him a key player in the organizations he has been part of. Murali is passionate about advancing the life sciences field and is known for his analytical approach to problem-solving. He currently resides in Boston, Massachusetts, where he continues to influence the biopharmaceutical landscape.
Murali Mallem
Work Experience
Vice President | Head of CMC at
Entrada Therapeutics
July 2022 - Present
Head of CMC at
Entrada Therapeutics
June 2019 - June 2022
Matrix Team Lead at
Bristol Myers Squibb
July 2016 - June 2019
Senior Bioengineer II at
SHIRE LIMITED
April 2014 - July 2016
Associate Principal Scientist at
Merck
June 2012 - April 2014
Sr. Research Biochemical Engineer at
Merck
October 2010 - May 2012
Research Biochemical Engineer at
Merck
August 2007 - September 2010
Process Development Associate at
Lonza
September 2005 - August 2007
Murali Mallem
Education
Emmanuel College, Ms
South Dakota Mines, Ms
Frequently Asked Questions about Murali Mallem
What company does Murali Mallem work for?
Murali Mallem is a Vice President | Head of CMC at Entrada Therapeutics, a company specializing in Commercial physical research.
Where Murali Mallem graduated from?
Murali Mallem holds a degree in Management from Emmanuel College.
Who is Murali Mallem?
Murali Mallem is an accomplished Vice President and Head of CMC at Entrada Therapeutics, specializing in the biopharmaceutical industry. With extensive experience in assay development, biochemistry, and biopharmaceuticals, he has held significant roles in leading teams and projects at top companies like Bristol Myers Squibb and Merck. His educational background includes advanced degrees in Chemical Engineering and Management, which complement his technical expertise. Murali's career spans over 18 years, showcasing a commitment to innovation in drug discovery and development processes. He has a proven track record in managing complex projects and driving technology transfer initiatives. His leadership style emphasizes collaboration and strategic thinking, making him a key player in the organizations he has been part of. Murali is passionate about advancing the life sciences field and is known for his analytical approach to problem-solving. He currently resides in Boston, Massachusetts, where he continues to influence the biopharmaceutical landscape.
Murali`s contact details
Colleagues
Vice President
Executive Director, FP&A
Executive Director
Vice President, Head of Cardiovascular and Neuromuscular & Cardiovascular Therapeutics
Chief Financial Officer and Treasurer
Board Member
Co-Founder & Vice President, Discovery Research
President Research And Development at Entrada Therapeutics
President and Chief Operating Officer
VP, Program Governance & Portfolio Management